Global E. Coli Testing Market Size, Status and Forecast 2019-2025

Escherichia coli (E. coli) are the leading cause of diarrheal diseases worldwide, especially among children. E. coli infection primarily occurs through food or drinking water contaminated with animal or human feces. The bacteria produce Shiga toxin that causes gastrointestinal (GI) infections with symptoms including bloody diarrhea and vomiting. Though the infections are usually cured in a few days, at times, they may lead to hemolytic uremic syndrome. This syndrome, if untreated, can result in kidney failure. E. coli tests are used to diagnose GI infections using stool samples. These tests can be performed using molecular diagnostic kits and immunoassays.
The increasing incidence of diarrhea across the globe is the primary growth driver for this market. Globally, around 2 billion cases of diarrheal disease occur every year. Diarrhea presents a higher risk for people above 65 years old and children under five years. E.coli testing is used for the diagnosis of GI infections that leads to diarrhea, hence, the increasing incidence of the diarrheal disease is creating a demand for such testing, thereby, leading to market growth.
The global E.coli testing market is fragmented, with intense competition among small and medium-sized manufacturers that provide E.coli test products. Also, the emerging economies of China, India, and Brazil present vast opportunities for the vendors to launch their E.coli test instrument and test kits. Therefore, vendors are associating with distributors and local vendors based in these emerging economies to enhance their position in the E.coli testing market.
In 2018, the global E. Coli Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global E. Coli Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the E. Coli Testing development in United States, Europe and China.

The key players covered in this study
Alere
Becton
Dickinson and Company (BD)
bioMérieux
Meridian Bioscience
Accugen Laboratories
Bio-Rad Laboratories
Diasorin
EIKEN CHEMICAL
Enzo Life Sciences
InstantLabs
Luminex Corporation
Mobidiag
Nanosphere
Pro-Lab Diagnostics
QIAGEN
Rome

Market segment by Type, the product can be split into
Consumables (assays, reagents, kits)
Instruments (laboratory benchtop devices)

Market segment by Application, split into
Molecular diagnostics
Immunoassay
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global E. Coli Testing status, future forecast, growth opportunity, key market and key players.
To present the E. Coli Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of E. Coli Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions